<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Acta Naturae</journal-id><journal-title-group><journal-title xml:lang="en">Acta Naturae</journal-title><trans-title-group xml:lang="ru"><trans-title>Acta Naturae</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-8251</issn><publisher><publisher-name xml:lang="en">Acta Naturae Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10326</article-id><article-id pub-id-type="doi">10.32607/20758251-2018-10-3-57-61</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Forum</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Форум</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Lynx1 Prevents Long-Term Potentiation Blockade and Reduction of Neuromodulator Expression Caused by Aβ1-42 and JNK Activation</article-title><trans-title-group xml:lang="ru"><trans-title>Lynx1 предотвращает нарушение долговременной потенциации и экспрессии нейромодулятора, вызванные Aβ1-42 и активацией JNK</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bychkov</surname><given-names>M. L.</given-names></name><name xml:lang="ru"><surname>Бычков</surname><given-names>M. Л.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ekaterina-lyukmanova@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vasilyeva</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Васильева</surname><given-names>Н. A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ekaterina-lyukmanova@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shulepko</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Шулепко</surname><given-names>M. A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ekaterina-lyukmanova@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Balaban</surname><given-names>P. M.</given-names></name><name xml:lang="ru"><surname>Балабан</surname><given-names>П. M.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ekaterina-lyukmanova@yandex.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kirpichnikov</surname><given-names>M. P.</given-names></name><name xml:lang="ru"><surname>Кирпичников</surname><given-names>M. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ekaterina-lyukmanova@yandex.ru</email><xref ref-type="aff" rid="aff6"/><xref ref-type="aff" rid="aff8"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lyukmanova</surname><given-names>E. N.</given-names></name><name xml:lang="ru"><surname>Люкманова</surname><given-names>E. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ekaterina-lyukmanova@yandex.ru</email><xref ref-type="aff" rid="aff6"/><xref ref-type="aff" rid="aff8"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Институт высшей нервной деятельности и нейрофизиологии человека РАН</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="ru">Институт высшей нервной деятельности и нейрофизиологии человека РАН</institution></aff><aff><institution xml:lang="en">Lomonosov Moscow State University</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff7"><aff><institution xml:lang="ru">Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН</institution></aff><aff><institution xml:lang="en">Lomonosov Moscow State University</institution></aff></aff-alternatives><aff id="aff8"><institution>Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН</institution></aff><pub-date date-type="pub" iso-8601-date="2018-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2018</year></pub-date><volume>10</volume><issue>3</issue><issue-title xml:lang="en">VOL 10, NO3 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 10, №3 (2018)</issue-title><fpage>57</fpage><lpage>61</lpage><history><date date-type="received" iso-8601-date="2020-01-17"><day>17</day><month>01</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Bychkov M.L., Vasilyeva N.A., Shulepko M.A., Balaban P.M., Kirpichnikov M.P., Lyukmanova E.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Бычков M.Л., Васильева Н.A., Шулепко M.A., Балабан П.M., Кирпичников M.П., Люкманова E.Н.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Bychkov M.L., Vasilyeva N.A., Shulepko M.A., Balaban P.M., Kirpichnikov M.P., Lyukmanova E.N.</copyright-holder><copyright-holder xml:lang="ru">Бычков M.Л., Васильева Н.A., Шулепко M.A., Балабан П.M., Кирпичников M.П., Люкманова E.Н.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://actanaturae.ru/2075-8251/article/view/10326">https://actanaturae.ru/2075-8251/article/view/10326</self-uri><abstract xml:lang="en"><p>Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels. Many neurodegenerative diseases are accompanied by cognitive impairment associated with the dysfunction of nAChRs. The human membrane-tethered prototoxin Lynx1 modulates nAChR function in the brain areas responsible for learning and memory. In this study, we have demonstrated for the first time that the β-amyloid peptide Aβ1-42 decreases Lynx1 mRNA expression in rat primary cortical neurons, and that this decrease is associated with the activation of c-Jun N-terminal kinase (JNK). In addition, we have demonstrated that the Lynx1 expression decrease, as well as the blockade of the long-term potentiation underlying learning and memory, caused by Aβ1-42, may be prevented by incubation with a water-soluble Lynx1 analogue. Our findings suggest that the water-soluble Lynx1 analogue may be a promising agent for the improvement of cognitive deficits in neurodegenerative diseases.</p></abstract><trans-abstract xml:lang="ru"><p>Никотиновые ацетилхолиновые рецепторы (nAChR) являются лигандзависимыми ионными каналами, дисфункция которых ассоциирована с когнитивными нарушениями, наблюдаемыми при нейродегенеративных заболеваниях. Мембраносвязанный белок Lynx1 модулирует работу nAChR в структурах мозга человека, важных для формирования памяти и обучения. В нашей работе впервые показано, что β-амилоидный пептид Aβ1-42 снижает уровень мРНК Lynx1 в первичных нейронах коры головного мозга крысы, и это снижение связано с активацией N-концевой киназы c-Jun (JNK). Кроме того, снижение уровня экспрессии Lynx1, равно как и нарушение долговременной потенциации, лежащей в основе механизмов синаптической пластичности, вызванные Aβ1-42, можно предотвратить, используя водорастворимый аналог Lynx1. Полученные данные указывают на водорастворимый Lynx1 как на препарат, потенциально способный улучшать когнитивные процессы при нейродегенеративных заболеваниях.</p></trans-abstract><kwd-group xml:lang="en"><kwd>nicotinic acetylcholine receptor</kwd><kwd>cognitive impairment</kwd><kwd>Alzheimer disease</kwd><kwd>β-amyloid peptide</kwd><kwd>Ly6/uPAR</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>бета-амилоид</kwd><kwd>болезнь Альцгеймера</kwd><kwd>когнитивные нарушения</kwd><kwd>никотиновый ацетилхолиновый рецептор</kwd><kwd>Ly6/uPAR</kwd></kwd-group><funding-group><funding-statement xml:lang="en">This work was supported by the Russian Foundation for Basic Research (No. 16-34-01302, N.A.V., development of a system for registering currents on brain slices) and RSF (No. 16-14-00102, E.N.L., M.A.Sh ., N.A.V., effect of Aβ1-42, SP600125, siRNAs and ws-Lynx1 on fiberboard and gene expression).</funding-statement><funding-statement xml:lang="ru">Работа выполнена при поддержке РФФИ (№ 16-34-01302, Н.А.В., разработка системы регистрации токов на срезах мозга) и РНФ (№ 16-14-00102, Е.Н.Л., М.А.Ш., Н.А.В., влияние Аβ1-42, SP600125, siРНК и ws-Lynx1 на ДВП и генную экспрессию).</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>[1] Buckingham S.D., Jones A.K., Brown L.A., Sattelle D.B. // Pharmacol. Rev. 2009, V.61, P.39-61</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>[2] Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. // Nature 2002, V.416, P.535-539</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>[3] Lynch M.A. // Physiol. Rev. 2004, V.84, P.87-136</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>[4] Lyukmanova E.N., Shenkarev Z.O., Shulepko M.A., Mineev K.S., D’Hoedt D., Kasheverov I.E., Filkin S.Y., Krivolapova A.P., Janickova H., Dolezal V., Dolgikh D.A. // J. Biol. Chem. 2011, V.286, P.10618-10627</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>[5] Miwa J.M., Ibanez-Tallon I., Crabtree G.W., Sánchez R., Sali A., Role L.W., Heintz N. // Neuron. 1999, V.23, P.105-114</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>[6] Thomsen M.S., Arvaniti M., Jensen M.M., Shulepko M.A., Dolgikh D.A., Pinborg L.H., Härtig W., Lyukmanova E.N., Mikkelsen J.D. // Neurobiol. Aging. 2016, V.46, P.13-21</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>[7] Suntsova M., Gogvadze E.V., Salozhin S., Gaifullin N., Eroshkin F., Dmitriev S.E., Martynova N., Kulikov K., Malakhova G., Tukhbatova G. // Proc. Natl. Acad. Sci. USA. 2013, V.110, P.19472-19477</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>[8] Klein W.L. // Neurochem. Int. 2002, V.41, P.345-352</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>[9] Hu M., Liu Q.S., Chang K.T., Berg D.K. // Mol. Cell. Neurosci. 2002, V.21, P.616-625</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>[10] Yarza R., Vela S., Solas M., Ramirez M.J. // Front. Pharmacol. 2016, V.6, 10.3389/fphar.2015.00321.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>[11] Yenki P., Khodagholi F., Shaerzadeh F. // J. Mol. Neurosci. 2013, V.49, P.262-269</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>[12] Wang Q., Walsh D.M., Rowan M.J., Selkoe D.J., Anwyl R. // J. Neurosci. 2004, V.24, P.3370-3378</mixed-citation></ref></ref-list></back></article>
